Article PDF
Literatur
Leffler DA, Lamont JT (2015) Clostridium difficile infection. N Engl J Med 372(16):1539–1548
Khanna S, Gupta A, Baddour LM, Pardi DS (2016) Epidemiology, outcomes, and predictors of mortality in hospitalized adults with Clostridium difficile infection. Intern Emerg Med 11(5):657–665
Gerding DN, Lessa FC (2015) The epidemiology of Clostridium difficile infection inside and outside health care institutions. Infect Dis Clin North Am 29(1):37–50
Magill SS, Edwards JR, Bamberg W et al (2014) Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370(13):1198–1208
Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen (NRZ) (2017) Deutsche nationale Punkt-Prävalenzerhebung zu nosokomialen Infektionen und Antibiotika-Anwendung 2016. Abschlussbericht. http://www.nrz-hygiene.de/fileadmin/nrz/download/pps2016/PPS_2016_Abschlussbericht_20.07.2017.pdf . Zugegriffen: 21. Febr. 2019
Robert Koch-Institut (RKI) (2017) Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2016. Robert Koch-Institut: Berlin. http://edoc.rki.de/docviews/abstract.php?id=5220 . Zugegriffen: 21. Febr. 2019
He M, Miyajima F, Roberts P et al (2013) Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 45(1):109–113
Martin J (2015) The contribution of strains and hosts to outcomes in Clostridium difficile infection. Infect Dis Clin North Am 29(1):51–61
Chitnis AS, Holzbauer SM, Belflower RM et al (2013) Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. Jama Intern Med 173(14):1359–1367
Bauer MP, Kuijper EJ (2015) Potential sources of Clostridium difficile in human infection. Infect Dis Clin North Am 29(1):29–35
Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) (2002) Ausbruchsmanagement und struktuiertes Vorgehen bei gehäuftem Auftreten nosokomialer Infektionen. Bundesgesundheitsbl 45(2):180–186
Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) (2016) Händehygiene in Einrichtungen des Gesundheitswesens. Bundesgesundheitsbl 59(9):1189–1220
Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) (2004) Empfehlung zu den Anforderungen an die Hygiene bei der Reinigung und Desinfektion von Flächen. Bundesgesundheitsbl 47(1):51–61
Kommision für Krankenhaushygiene und Infektionsprävention (KRINKO) (2015) Infektionsprävention im Rahmen der Pflege und Behandlung von Patienten mit übertragbaren Krankheiten. Bundesgesundheitsbl 58(10):1151–1170
Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) (2010) Die Kategorien der Richtlinie für Krankenhaushygiene und Infektionsprävention – Aktualisierung der Definitionen. Bundesgesundheitsbl 53(7):754–756
Rupnik M, Wilcox MH, Gerding DN (2009) Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7(7):526–536
Lübbert C, John E, von Müller L (2014) Clostridium-difficile-Infektion. Leitliniengerechte Diagnostik- und Behandlungsoptionen. Dtsch Arztebl 111(43):723–e713
Martin JS, Monaghan TM, Wilcox MH (2016) Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat Rev Gastroenterol Hepatol 13(4):206–216
Monaghan TM (2015) New perspectives in Clostridium difficile disease pathogenesis. Infect Dis Clin North Am 29(1):1–11
Smits WK, Lyras D, Lacy DB, Wilcox MH, Kuijper EJ (2016) Clostridium difficile infection. Nat Rev Dis Primers 2:16020
Sorg JA, Sonenshein AL (2008) Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol 190(7):2505–2512
Wilson KH (1983) Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination. J Clin Microbiol 18(4):1017–1019
Britton RA, Young VB (2012) Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol 20(7):313–319
McDonald LC, Killgore GE, Thompson A et al (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353(23):2433–2441
von Müller L, Halfmann A, Herrmann M (2012) Aktuelle Daten und Trends zur Antibiotikaresistenzentwicklung von Clostridium difficile. Bundesgesundheitsbl 55(11–12):1410–1417
Loo VG, Poirier L, Miller MA et al (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353(23):2442–2449
Aldeyab MA, Devine MJ, Flanagan P et al (2011) Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures. Infect Control Hosp Epidemiol 32(3):210–219
Alam MJ, Anu A, Walk ST, Garey KW (2014) Investigation of potentially pathogenic Clostridium difficile contamination in household environs. Anaerobe 27:31–33
Rodriguez-Palacios A, Stampfli HR, Duffield T et al (2006) Clostridium difficile PCR ribotypes in calves. Canada Emerg Infect Dis 12(11):1730–1736
Keel K, Brazier JS, Post KW, Weese S, Songer JG (2007) Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J Clin Microbiol 45(6):1963–1964
Hensgens MPM, Keessen EC, Squire MM et al (2012) Clostridium difficile infection in the community: a zoonotic disease? Clin Microbiol Infect 18(7):635–645
Dahms C, Hübner NO, Wilke F, Kramer A (2014) Mini-review: Epidemiology and zoonotic potential of multiresistant bacteria and Clostridium difficile in livestock and food. Gms Hyg Infect Control 9(3):Doc21
Keessen EC, Harmanus C, Dohmen W, Kuijper EJ, Lipman LJ (2013) Clostridium difficile infection associated with pig farms. Emerg Infect Dis 19(6):1032–1034
Al-Jumaili IJ, Shibley M, Lishman AH, Record CO (1984) Incidence and origin of Clostridium difficile in neonates. J Clin Microbiol 19(1):77–78
Bolton RP, Tait SK, Dear PR, Losowsky MS (1984) Asymptomatic neonatal colonisation by Clostridium difficile. Arch Dis Child 59(5):466–472
Ozaki E, Kato H, Kita H et al (2004) Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization. J Med Microbiol 53(Pt 2):167–172
Arvand M, Moser V, Schwehn C, Bettge-Weller G, Hensgens MP, Kuijper EJ (2012) High prevalence of Clostridium difficile colonization among nursing home residents in Hesse, Germany. PLoS ONE 7(1):e30183
Yakob L, Riley TV, Paterson DL, Clements AC (2013) Clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model. Bmc Infect Dis 13:376
Marwick CA, Yu N, Lockhart MC et al (2013) Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control. J Antimicrob Chemother 68(12):2927–2933
Ziakas PD, Zacharioudakis IM, Zervou FN, Grigoras C, Pliakos EE, Mylonakis E (2015) Asymptomatic carriers of toxigenic C. difficile in long-term care facilities: A meta-analysis of prevalence and risk factors. PLoS ONE 10(2):e117195
Donskey CJ, Kundrapu S, Deshpande A (2015) Colonization versus carriage of Clostridium difficile. Infect Dis Clin North Am 29(1):13–28
Lee YJ, Arguello ES, Jenq RR et al (2017) Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. J Infect Dis 215(7):1117–1123
Sun X, Hirota SA (2015) The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection. Mol Immunol 63(2):193–202
Ghose C, Kelly CP (2015) The prospect for vaccines to prevent Clostridium difficile infection. Infect Dis Clin North Am 29(1):145–162
Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen (NRZ) (2017) KISS Krankenhaus-Infektions-Surveillance-System. Modul CDAD-KISS. Referenzdaten, 2017. http://www.nrz-hygiene.de/fileadmin/nrz/module/cdad/201701_201712_CDADRef.pdf . Zugegriffen: 21. Febr. 2019
Cassini A, Plachouras D, Eckmanns T et al (2016) Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study. Plos Med 13(10):e1002150
Robert Koch-Institut (RKI), Weiß B (2014) Schwer verlaufende Clostridium-difficile-Infektionen: IfSGSurveillancedaten von 2013. Epid Bull 27:233–237
Wiegand PN, Nathwani D, Wilcox MH, Stephens J, Shelbaya A, Haider S (2012) Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. J Hosp Infect 81(1):1–14
Arvand M, Hauri AM, Zaiss NH, Witte W, Bettge-Weller G (2009) Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany. Euro Surveill 14(45). https://doi.org/10.25646/411
Kelly CP, LaMont JT (2008) Clostridium difficile-more difficult than ever. N Engl J Med 359(18):1932–1940
Freeman J, Bauer MP, Baines SD et al (2010) The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 23(3):529–549
Kwon JH, Olsen MA, Dubberke ER (2015) The morbidity, mortality, and costs associated with Clostridium difficile infection. Infect Dis Clin North Am 29(1):123–134
Lessa FC, Mu Y, Bamberg WM et al (2015) Burden of Clostridium difficile infection in the United States. N Engl J Med 372(9):825–834
Bauer MP, Notermans DW, van Benthem BH et al (2011) Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377(9759):63–73
Kleinkauf N, Weiss B, Jansen A et al (2007) Confirmed cases and report of clusters of severe infections due to Clostridium difficile PCR ribotype 027 in Germany. Euro Surveill 12(46):3307
Arvand M, Vollandt D, Bettge-Weller G, Harmanus C, Kuijper EJ (2014) Increased incidence of Clostridium difficile PCR ribotype 027 in Hesse, Germany, 2011 to 2013. Euro Surveill 19(10):20732
von Müller L, Mock M, Halfmann A, Stahlmann J, Simon A, Herrmann M (2015) Epidemiology of Clostridium difficile in Germany based on a single center long-term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons. Int J Med Microbiol 305(7):807–813
Arvand M, Bettge-Weller G (2016) Clostridium difficile ribotype 027 is not evenly distributed in Hesse, Germany. Anaerobe 40:1–4
Arvand M, Hauri AM, Zaiss NH, Witte W, Bettge-Weller G (2010) Schwer verlaufende Clostridium-difficile-Infektionen in Hessen 2008–2009. Dtsch Med Wochenschr 135(40):1963–1967
Berger FBM, Strauß C, von Müller L, Gärtner B (2017) Auftreten von Clostridium difficile Ribotyp 176 in Deutschland. Epid Bull 10:93–95
von Muller L, Mock M, Halfmann A, Stahlmann J, Simon A, Herrmann M (2015) Epidemiology of Clostridium difficile in Germany based on a single center long-term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons. Int J Med Microbiol 305(7):807–813
Goorhuis A, van Dissel JT, Kuijper EJ (2008) Novel risk factors for Clostridium difficile-associated disease in a setting of endemicity? Clin Infect Dis 47(3):429–430
Keessen EC, Gaastra W, Lipman LJ (2011) Clostridium difficile infection in humans and animals, differences and similarities. Vet Microbiol 153(3/4):205–217
Dormann A, Weinke T (2015) Clostridium-difficile-Infektionen ein zunehmendes Problem in deutschen Krankenhäusern. Klinikarzt 39(1):2–10
Kelly CP, LaMont JT (2016) Antibiotic-associated diarrhoea and Clostridium difficile Infection. In: Feldman M, Friedman L, Bradt LJ (Hrsg) Sleisenger & Fordtran’s. Gastrointestinal and Liver Disease—Pathophysiology, Diagnosis, Management, 10. Aufl. Elsevier Saunders, Philadelphia, S 1939–1954
Tschudin-Sutter S, Carroll KC, Tamma PD et al (2015) Impact of toxigenic Clostridium difficile colonization on the risk of subsequent C. difficile infection in intensive care unit patients. Infect Control Hosp Epidemiol 36(11):1324–1329
Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN (1992) Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 166(3):561–567
Bruminhent J, Wang ZX, Hu C et al (2014) Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transpl 20(9):1329–1334
Nissle K, Kopf D, Rosler A (2016) Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients. Bmc Geriatr 16(1):185
Wieczorkiewicz JT, Lopansri BK, Cheknis A et al (2015) Fluoroquinolone and macrolide exposure predict Clostridium difficile infection with the highly fluoroquinolone- and macrolide-resistant epidemic C. difficile Strain BI/NAP1/027. Antimicrob Agents Chemother 60(1):418–423
Hensgens MPM, Goorhuis A, Dekkers OM, Kuijper EJ (2012) Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother 67(3):742–748
Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E (2011) Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis 53(1):42–48
Shin JH, High KP, Warren CA (2016) Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections. J Gerontol A Biol Sci Med Sci 71(7):916–922
Vesteinsdottir I, Gudlaugsdottir S, Einarsdottir R, Kalaitzakis E, Sigurdardottir O, Bjornsson ES (2012) Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study. Eur J Clin Microbiol Infect Dis 31(10):2601–2610
Murphy CR, Avery TR, Dubberke ER, Huang SS (2012) Frequent hospital readmissions for Clostridium difficile infection and the impact on estimates of hospital-associated C. difficile burden. Infect Control Hosp Epidemiol 33(1):20–28
Furuya-Kanamori L, Stone JC, Clark J et al (2015) Comorbidities, exposure to medications, and the risk of community-acquired Clostridium difficile infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 36(2):132–141
Paudel S, Zacharioudakis IM, Zervou FN, Ziakas PD, Mylonakis E (2015) Prevalence of Clostridium difficile infection among solid organ transplant recipients: a meta-analysis of published studies. PLoS ONE 10(4):e124483
Lübbert C, Johann C, Kekule AS et al (2013) Immunsuppressive Behandlung als Risikofaktor für das Auftreten einer Clostridium-difficile-Infektion (CDI). Z Gastroenterol 51(11):1251–1258
Ricciardi R, Ogilvie JW Jr., Roberts PL, Marcello PW, Concannon TW, Baxter NN (2009) Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases. Dis Colon Rectum 52(1):40–45
Kim SC, Seo MY, Lee JY et al (2016) Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection. Korean J Intern Med 31(1):125–133
Simor AE, Bradley SF, Strausbaugh LJ, Crossley K, Nicolle LE (2002) Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol 23(11):696–703
Aseeri M, Schroeder T, Kramer J, Zackula R (2008) Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol 103(9):2308–2313
Arriola V, Tischendorf J, Musuuza J, Barker A, Rozelle JW, Safdar N (2016) Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis. Infect Control Hosp Epidemiol 37(12):1408–1417
Cao F, Chen CX, Wang M et al (2018) Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection. J Hosp Infect 98(1):4–13
Oshima T, Wu L, Li M, Fukui H, Watari J, Miwa H (2018) Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis. J Gastroenterol 53(1):84–94
Tleyjeh IM, Bin Abdulhak AA, Riaz M et al (2012) Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis. PLoS ONE 7(12):e50836
Trifan A, Stanciu C, Girleanu I et al (2017) Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis. World J Gastroenterol 23(35):6500–6515
Freedberg DE, Lamouse-Smith ES, Lightdale JR, Jin Z, Yang YX, Abrams JA (2015) Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study. Clin Infect Dis 61(6):912–917
Tariq R, Singh S, Gupta A, Pardi DS, Khanna S (2017) Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis. Jama Intern Med 177(6):784–791
Fekety R, McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Mulligan ME (1997) Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 24(3):324–333
Hu MY, Katchar K, Kyne L et al (2009) Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Baillieres Clin Gastroenterol 136(4):1206–1214
Eyre DW, Walker AS, Wyllie D et al (2012) Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clin Infect Dis 55(Suppl 2):S77–87
Petrella LA, Sambol SP, Cheknis A et al (2012) Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis 55(3):351–357
Marsh JW, Arora R, Schlackman JL, Shutt KA, Curry SR, Harrison LH (2012) Association of relapse of Clostridium difficile disease with BI/NAP1/027. J Clin Microbiol 50(12):4078–4082
Davies KA, Longshaw CM, Davis GL et al (2014) Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis 14(12):1208–1219
Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2015) S2k-Leitlinie. Gastrointestinale Infektionen und Morbus Whipple. AWMF-Registernummer 021/024. http://www.awmf.org/leitlinien/detail/ll/021-024.html . Zugegriffen: 21. Febr. 2019
Barbut F, Surgers L, Eckert C et al (2014) Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management? Clin Microbiol Infect 20(2):136–144
Crobach MJ, Planche T, Eckert C et al (2016) European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect 22(Suppl 4):S63–81
European Centre for Disease Prevention and Control (ECDC) (2018) Technical Report. Laboratory procedures for diagnosis and typing of human Clostridium difficile infection. ECDC: Stockholm. https://ecdc.europa.eu/sites/portal/files/documents/SOPs-Clostridium-difficile-diagnosis-and-typing.pdf . Zugegriffen: 21. Febr. 2019
Tschudin-Sutter S, Kuijper EJ, Durovic A et al (2018) Guidance document for prevention of Clostridium difficile infection in acute healthcare settings. Clin Microbiol Infect 24(10):1051–1054
Planche T, Wilcox MH (2015) Diagnostic pitfalls in Clostridium difficile infection. Infect Dis Clin North Am 29(1):63–82
Kundrapu S, Sunkesula VC, Jury LA, Sethi AK, Donskey CJ (2012) Utility of perirectal swab specimens for diagnosis of Clostridium difficile infection. Clin Infect Dis 55(11):1527–1530
Rogers DS, Kundrapu S, Sunkesula VCK, Donskey CJ (2013) Comparison of perirectal versus rectal swabs for detection of asymptomatic carriers of toxigenic Clostridium difficile. J Clin Microbiol 51(10):3421–3422
Deshpande A, Pasupuleti V, Patel P et al (2011) Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield. Clin Gastroenterol Hepatol 9(8):665–669.e1
Nistico JA, Hage JE, Schoch PE, Cunha BA (2013) Unnecessary repeat Clostridium difficile PCR testing in hospitalized adults with C. difficile-negative diarrhea. Eur J Clin Microbiol Infect Dis 32(1):97–99
Nationales Referenzzentrum für Clostridium difficile (NRZ) http://www.uniklinikum-saarland.de/einrichtungen/kliniken_institute/infektionsmedizin/medizinische_mikrobiologie_und_hygiene/krankenhaushygiene/nationales_referenzzentrum_fuer_clostridium_difficile/ . Zugegriffen: 21. Febr. 2018
Berdichevski T, Keller N, Rahav G, Bar-Meir S, Eliakim R, Ben-Horin S (2013) The impact of pseudomembrane formation on the outcome of Clostridium difficile-associated disease. Infection 41(5):969–977
Jangi S, Lamont JT (2010) Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr 51(1):2–7
Weichert S, Simon A, von Müller L, Adam R, Schroten H (2015) Clostridium-difficile-assoziierte Infektionen im Kindes- und Jugendalter. Monatsschr Kinderheilkd 163(5):427
Borali E, De Giacomo C (2016) Clostridium Difficile Infection in Children: A Review. J Pediatr Gastroenterol Nutr 63(6):e130–e140
Enoch DA, Butler MJ, Pai S, Aliyu SH, Karas JA (2011) Clostridium difficile in children: colonisation and disease. J Infect 63(2):105–113
Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen (NRZ) (2016) KISS Krankenhaus-Infektions-Surveillance-System. Modul CDAD-KISS. Referenzdaten, 2016. http://www.nrz-hygiene.de/surveillance/kiss/cdad-kiss/ . Zugegriffen: 21. Febr. 2019
Barker AK, Ngam C, Musuuza JS, Vaughn VM, Safdar N (2017) Reducing Clostridium difficile in the Inpatient Setting: A Systematic Review of the Adherence to and Effectiveness of C. difficile Prevention Bundles. Infect Control Hosp Epidemiol 38(6):639–650
Yakob L, Riley TV, Paterson DL, Marquess J, Clements AC (2014) Assessing control bundles for Clostridium difficile: a review and mathematical model. Emerg Microbes Infect 3(6):e43
Khanafer N, Voirin N, Barbut F, Kuijper E, Vanhems P (2015) Hospital management of Clostridium difficile infection: a review of the literature. J Hosp Infect 90(2):91–101
Loo VG (2015) Environmental interventions to control Clostridium difficile. Infect Dis Clin North Am 29(1):83–91
Louh IK, Greendyke WG, Hermann EA et al (2017) Clostridium Difficile Infection in Acute Care Hospitals: Systematic Review and Best Practices for Prevention. Infect Control Hosp Epidemiol 38(4):476–482
Collins DA, Hawkey PM, Riley TV (2013) Epidemiology of Clostridium difficile infection in Asia. Antimicrob Resist Infect Control 2(1):21
Longtin Y, Paquet-Bolduc B, Gilca R et al (2016) Effect of detecting and isolating Clostridium difficile carriers at hospital admission on the incidence of C. difficile infections: A quasi-experimental controlled study. Jama Intern Med 176(6):796–804
Blixt T, Gradel KO, Homann C et al (2017) Asymptomatic Carriers Contribute to Nosocomial Clostridium difficile Infection: A Cohort Study of 4508 Patients. Baillieres Clin Gastroenterol 152(5):1031–1041
Curry SR, Muto CA, Schlackman JL et al (2013) Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis 57(8):1094–1102
Eyre DW, Griffiths D, Vaughan A et al (2013) Asymptomatic Clostridium difficile colonisation and onward transmission. PLoS ONE 8(11):e78445
Grigoras CA, Zervou FN, Zacharioudakis IM, Siettos CI, Mylonakis E (2016) Isolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data. PLoS ONE 11(6):e156577
Kaatz GW, Gitlin SD, Schaberg DR et al (1988) Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 127(6):1289–1294
Samore MH, Venkataraman L, DeGirolami PC, Arbeit RD, Karchmer AW (1996) Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 100(1):32–40
Barbut F, Menuet D, Verachten M, Girou E (2009) Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol 30(6):507–514
Hill KA, Collins J, Wilson L, Perry JD, Gould FK (2013) Comparison of two selective media for the recovery of Clostridium difficile from environmental surfaces. J Hosp Infect 83(2):164–166
Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ (2007) Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 45(8):992–998
Chang VT, Nelson K (2000) The role of physical proximity in nosocomial diarrhea. Clin Infect Dis 31(3):717–722
Shaughnessy MK, Micielli RL, DePestel DD et al (2011) Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 32(3):201–206
Freedberg DE, Salmasian H, Cohen B, Abrams JA, Larson EL (2016) Receipt of Antibiotics in Hospitalized Patients and Risk for Clostridium difficile Infection in Subsequent Patients Who Occupy the Same Bed. Jama Intern Med 176(12):1801–1808
Mitchell BG, Dancer SJ, Anderson M, Dehn E (2015) Risk of organism acquisition from prior room occupants: a systematic review and meta-analysis. J Hosp Infect 91(3):211–217
Widmer AF, Frei R, Erb S et al (2017) Transmissibility of Clostridium difficile Without Contact Isolation: Results From a Prospective Observational Study With 451 Patients. Clin Infect Dis 64(4):393–400
McFarland LV, Mulligan ME, Kwok RY, Stamm WE (1989) Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 320(4):204–210
Forster AJ, Daneman N, van Walraven C (2017) Influence of antibiotics and case exposure on hospital-acquired Clostridium difficile infection independent of illness severity. J Hosp Infect 95(4):400–409
Teltsch DY, Hanley J, Loo V, Goldberg P, Gursahaney A, Buckeridge DL (2011) Infection acquisition following intensive care unit room privatization. Arch Intern Med 171(1):32–38
Abbett SK, Yokoe DS, Lipsitz SR et al (2009) Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection. Infect Control Hosp Epidemiol 30(11):1062–1069
Figueroa I, Johnson S, Sambol SP, Goldstein EJ, Citron DM, Gerding DN (2012) Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Clin Infect Dis 55(Suppl 2):S104–S109
Aogain MM, Moloney G, Kilkenny S et al (2015) Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections. J Hosp Infect 90(2):108–116
Islam J, Cheek E, Navani V, Rajkumar C, Cohen J, Llewelyn MJ (2013) Influence of cohorting patients with Clostridium difficile infection on risk of symptomatic recurrence. J Hosp Infect 85(1):17–21
Al-Nassir WN, Sethi AK, Nerandzic MM, Bobulsky GS, Jump RL, Donskey CJ (2008) Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin. Clin Infect Dis 47(1):56–62
Sethi AK, Al-Nassir WN, Nerandzic MM, Bobulsky GS, Donskey CJ (2010) Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol 31(1):21–27
Banach DB, Bearman G, Barnden M et al (2018) Duration of Contact Precautions for Acute-Care Settings. Infect Control Hosp Epidemiol 39(2):127–144
Surawicz CM, Brandt LJ, Binion DG et al (2013) Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108(4):478–498
Dubberke ER, Carling P, Carrico R et al (2014) Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update. Infect Control Hosp Epidemiol 35(6):628–645
Martin M, Zingg W, Knoll E, Wilson C, Dettenkofer M, Group PS (2014) National European guidelines for the prevention of Clostridium difficile infection: a systematic qualitative review. J Hosp Infect 87(4):212–219
Fekety R, Kim KH, Brown D, Batts DH, Cudmore M, Silva J Jr. (1981) Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment. Am J Med 70(4):906–908
Bobulsky GS, Al-Nassir WN, Riggs MM, Sethi AK, Donskey CJ (2008) Clostridium difficile skin contamination in patients with C. difficile-associated disease. Clin Infect Dis 46(3):447–450
DIN EN 14126:2004-01 Schutzkleidung—Leistungsanforderungen und Prüfverfahren für Schutzkleidung gegen Infektionserreger; Deutsche Fassung EN 14126:2003. Beuth: Berlin
Deutsche Gesellschaft für Krankenhaushygiene (DGKH) (2015) Schutzkittel bei medizinischen und pflegerischen Tätigkeiten sowie bei Barrieremaßnahmen und Isolierungen. Hyg Med 40(1):59–60
Kim KH, Fekety R, Batts DH et al (1981) Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 143(1):42–50
Roberts K, Smith CF, Snelling AM et al (2008) Aerial dissemination of Clostridium difficile spores. Bmc Infect Dis 8:7
Landelle C, Verachten M, Legrand P et al (2014) Contamination of healthcare workers’ hands with Clostridium difficile spores after caring for patients with C. difficile infection. Infect Control Hosp Epidemiol 35(1):10–15
Johnson S, Gerding DN, Olson MM et al (1990) Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 88(2):137–140
Oughton MT, Loo VG, Dendukuri N, Fenn S, Libman MD (2009) Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile. Infect Control Hosp Epidemiol 30(10):939–944
Jabbar U, Leischner J, Kasper D et al (2010) Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol 31(6):565–570
Gordin FM, Schultz ME, Huber RA, Gill JA (2005) Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub. Infect Control Hosp Epidemiol 26(7):650–653
Stone SP, Fuller C, Savage J et al (2012) Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ 344:e3005
Boyce JM, Ligi C, Kohan C, Dumigan D, Havill NL (2006) Lack of association between the increased incidence of Clostridium difficile-associated disease and the increasing use of alcohol-based hand rubs. Infect Control Hosp Epidemiol 27(5):479–483
Bettin K, Clabots C, Mathie P, Willard K, Gerding DN (1994) Effectiveness of liquid soap vs. chlorhexidine gluconate for the removal of Clostridium difficile from bare hands and gloved hands. Infect Control Hosp Epidemiol 15(11):697–702
Nerandzic MM, Rackaityte E, Jury LA, Eckart K, Donskey CJ (2013) Novel strategies for enhanced removal of persistent Bacillus anthracis surrogates and Clostridium difficile spores from skin. PLoS ONE 8(7):e68706
Duerden BI (2011) Contribution of a government target to controlling Clostridium difficile in the NHS in England. Anaerobe 17(4):175–179
Noto MJ, Domenico HJ, Byrne DW et al (2015) Chlorhexidine bathing and health care-associated infections: a randomized clinical trial. JAMA 313(4):369–378
Dubberke ER, Reske KA, Noble-Wang J et al (2007) Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control 35(5):315–318
Sjoberg M, Eriksson M, Andersson J, Noren T (2014) Transmission of Clostridium difficile spores in isolation room environments and through hospital beds. APMIS 122(9):800–803
Weber DJ, Anderson DJ, Sexton DJ, Rutala WA (2013) Role of the environment in the transmission of Clostridium difficile in health care facilities. Am J Infect Control 41(5 Suppl):S105–S110
Mayfield JL, Leet T, Miller J, Mundy LM (2000) Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 31(4):995–1000
Apisarnthanarak A, Zack JE, Mayfield JL et al (2004) Effectiveness of environmental and infection control programs to reduce transmission of Clostridium difficile. Clin Infect Dis 39(4):601–602
Bond WW, Ott JB, Franke KA, McCracken JE (1991) Effective use of liquid chemical germicides on medical devices: instrument design problems. In: Block SS (Hrsg) Disinfection, sterilization and preservation, 4. Aufl. Lea & Febiger, Philadelphia, S 1097–1106
Dawson LF, Valiente E, Donahue EH, Birchenough G, Wren BW (2011) Hypervirulent Clostridium difficile PCR-ribotypes exhibit resistance to widely used disinfectants. PLoS ONE 6(10):e25754
Russell AD (1999) Bacterial resistance to disinfectants: present knowledge and future problems. J Hosp Infect 43(Suppl):S57–S68
Russell AD (1990) Bacterial spores and chemical sporicidal agents. Clin Microbiol Rev 3(2):99–119
Desinfektionsmittel-Kommission im Verbund für Angewandte Hygiene (VAH) Anforderungen und Methoden zur VAH-Zertifizierung chemischer Desinfektionsverfahren. 3. Ergänzungslieferung. Stand: 15. Oktober 2018. mph-Verlag: Wiesbaden
DIN EN 17126:2017-06 (Entwurf) Chemische Desinfektionsmittel und Antiseptika – Quantitativer Suspensionsversuch zur Bestimmung der sporiziden Wirkung im humanmedizinischen Bereich – Prüfverfahren und Anforderungen (Phase 2, Stufe 1); Deutsche und Englische Fassung prEN 17126:2017. Beuth: Berlin
Verbund für Angewandte Hygiene (VAH) (2017) Empfehlung zur Auswahl sporizider Desinfektionsmittel bei Clostridium-difficile-Infektionen im human-medizinischen Bereich. Hyg Med 42(1/2):38
Wilcox MH, Fawley WN, Wigglesworth N, Parnell P, Verity P, Freeman J (2003) Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect 54(2):109–114
Eckstein BC, Adams DA, Eckstein EC et al (2007) Reduction of Clostridium Difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods. Bmc Infect Dis 7:61
Kundrapu S, Sunkesula V, Jury LA, Sitzlar BM, Donskey CJ (2012) Daily disinfection of high-touch surfaces in isolation rooms to reduce contamination of healthcare workers’ hands. Infect Control Hosp Epidemiol 33(10):1039–1042
Sitzlar B, Deshpande A, Fertelli D, Kundrapu S, Sethi AK, Donskey CJ (2013) An environmental disinfection odyssey: evaluation of sequential interventions to improve disinfection of Clostridium difficile isolation rooms. Infect Control Hosp Epidemiol 34(5):459–465
Dumford DM, Nerandzic MM, Eckstein BC, Donskey CJ (2009) What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains. Am J Infect Control 37(1):15–19
Canadian Agency for Drugs and Technologies in Health (CADTH) (2014) Non-Manual techniques for room disinfection in healthcare facilities: A review of clinical effectiveness and guidelines. (Rapid Response Report: Summary with Critical Appraisal). https://www.ncbi.nlm.nih.gov/pubmedhealth/n/rc0545/pdf . Zugegriffen: 21. Febr. 2019
Manian FA, Griesnauer S, Bryant A (2013) Implementation of hospital-wide enhanced terminal cleaning of targeted patient rooms and its impact on endemic Clostridium difficile infection rates. Am J Infect Control 41(6):537–541
Boyce JM, Havill NL, Otter JA et al (2008) Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol 29(8):723–729
Levin J, Riley LS, Parrish C, English D, Ahn S (2013) The effect of portable pulsed xenon ultraviolet light after terminal cleaning on hospital-associated Clostridium difficile infection in a community hospital. Am J Infect Control 41(8):746–748
Robert Koch-Institut (RKI) (2013) 3.3 Raumdesinfektion. In: Robert Koch-Institut (RKI) Liste der vom Robert Koch-Institut geprüften und anerkannten Desinfektionsmittel und -verfahren. Bundesgesundheitsbl 56(12):1706–1728
Reichenbacher D, Thanheiser M, Krüger D (2010) Aktueller Stand zur Raumdekontamination mit gasförmigem Wasserstoffperoxid Status quo of room decontamination by vaporized hydrogen peroxide. Hyg Med 35(6):204–208
Byrns G, Fuller TP (2011) The risks and benefits of chemical fumigation in the health care environment. J Occup Environ Hyg 8(2):104–112
Popp W (2014) Probleme bei der Etablierung eines Wasserstoffperoxid-Verneblers. Hyg Med 39(3):77–80
Manian FA, Meyer L, Jenne J (1996) Clostridium difficile contamination of blood pressure cuffs: a call for a closer look at gloving practices in the era of universal precautions. Infect Control Hosp Epidemiol 17(3):180–182
Vajravelu RK, Guerrero DM, Jury LA, Donskey CJ (2012) Evaluation of stethoscopes as vectors of Clostridium difficile and methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 33(1):96–98
Brooks S, Khan A, Stoica D et al (1998) Reduction in vancomycin-resistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers. Infect Control Hosp Epidemiol 19(5):333–336
Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) (2012) Empfehlung zu den Anforderungen an die Hygiene bei der Aufbereitung von Medizinprodukten. Bundesgesundheitsbl 55(10):1244–1310
Kampf G (2008) Clostridium difficile – was ist für eine effektive Desinfektion zu beachten? Hyg Med 33(4):153–159
Nystrom B (1983) Disinfection in bed-pan washers. J Hosp Infect 4(2):191–198
Alfa MJ, Olson N, Buelow-Smith L (2008) Simulated-use testing of bedpan and urinal washer disinfectors: evaluation of Clostridium difficile spore survival and cleaning efficacy. Am J Infect Control 36(1):5–11
Alfa MJ, Olson N, Buelow-Smith L, Murray BL (2013) Alkaline detergent combined with a routine ward bedpan washer disinfector cycle eradicates Clostridium difficile spores from the surface of plastic bedpans. Am J Infect Control 41(4):381–383
MacDonald K, Bishop J, Dobbyn B, Kibsey P, Alfa MJ (2016) Reproducible elimination of Clostridium difficile spores using a clinical area washer disinfector in 3 different health care sites. Am J Infect Control 44(7):e107–e111
Muscarella LF (2010) Evaluation of the risk of transmission of bacterial biofilms and Clostridium difficile during gastrointestinal endoscopy. Gastroenterol Nurs 33(1):28–35
Kovaleva J, Peters FTM, van der Mei HC, Degener JE (2013) Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy. Clin Microbiol Rev 26(2):231–254
Pokrywka M, Buraczewski M, Frank D et al (2017) Can improving patient hand hygiene impact Clostridium difficile infection events at an academic medical center? Am J Infect Control 45(9):959–963
Pokrywka M, Feigel J, Douglas B et al (2014) A bundle strategy including patient hand hygiene to decrease clostridium difficile infections. Medsurg Nurs 23(3):145–148
Munoz-Price LS, Banach DB, Bearman G et al (2015) Isolation precautions for visitors. Infect Control Hosp Epidemiol 36(7):747–758
Ramphal L, Suzuki S, McCracken IM, Addai A (2014) Improving hospital staff compliance with environmental cleaning behavior. Proc (bayl Univ Med Cent) 27(2):88–91
Guerrero DM, Carling PC, Jury LA, Ponnada S, Nerandzic MM, Donskey CJ (2013) Beyond the Hawthorne effect: reduction of Clostridium difficile environmental contamination through active intervention to improve cleaning practices. Infect Control Hosp Epidemiol 34(5):524–526
Tomas ME, Sunkesula VC, Kundrapu S, Wilson BM, Donskey CJ (2015) An intervention to reduce health care personnel hand contamination during care of patients with Clostridium difficile infection. Am J Infect Control 43(12):1366–1367
Deutsche Gesellschaft für Infektiologie e. V. (DGI), Bundesverband Deutscher Krankenhausapotheker e. V. (ADKA), Deutsche Gesellschaft für Hygiene und Mikrobiologie (DGHM) et al. (2013) S3-Leitlinie. Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus. AWMF-Registernummer 092/001. http://www.awmf.org/leitlinien/detail/ll/092-001.html . Zugegriffen: 21. Febr. 2019
Brown K, Valenta K, Fisman D, Simor A, Daneman N (2015) Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. Jama Intern Med 175(4):626–633
Sandora TJ, Fung M, Flaherty K et al (2011) Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr Infect Dis J 30(7):580–584
Balch A, Wendelboe AM, Vesely SK, Bratzler DW (2017) Antibiotic prophylaxis for surgical site infections as a risk factor for infection with Clostridium difficile. PLoS ONE 12(6):e179117
Poeran J, Mazumdar M, Rasul R et al (2016) Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 151(2):589–597
McDonald LC, Gerding DN, Johnson S et al (2018) Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 66(7):e1–e48
Shaughnessy MK, Amundson WH, Kuskowski MA, DeCarolis DD, Johnson JR, Drekonja DM (2013) Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection. Infect Control Hosp Epidemiol 34(2):109–116
Zweigner J, Meyer E, Gastmeier P, Schwab F (2018) Rate of antibiotic prescriptions in German outpatient care—are the guidelines followed or are they still exceeded? Gms Hyg Infect Control 13:Doc4
Kommission ART (16.02.2017) Voraussetzungen und Strategien für die erfolgreiche Implementierung infektiologischer Leitlinien – Positionspapier der Kommission ART. Positionspapier der Kommission Antiinfektiva, Resistenz und Therapie (Kommission ART) beim Robert Koch-Institut. https://www.rki.de/DE/Content/Kommissionen/ART/Positionspapier/Positionspapier_Leitlinien_Implementierung.html . Zugegriffen: 21. Febr. 2019
de With K (2017) Infektiologische Leitlinien: Nur die praktische Anwendung zählt. Dtsch Arztebl 114(8):A-368/B-318/C-311
Slimings C, Riley TV (2014) Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother 69(4):881–891
Feazel LM, Malhotra A, Perencevich EN, Kaboli P, Diekema DJ, Schweizer ML (2014) Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. J Antimicrob Chemother 69(7):1748–1754
Baur D, Gladstone BP, Burkert F et al (2017) Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis 17(9):990–1001
European Centre for Disease Prevention and Control (ECDC) (2016) Proposals for draft EU guidelines on the prudent use of antimicrobials in human medicine. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/draft-EU-guidelines-prudent-use-antimicrobials-human-medicine.pdf . Zugegriffen: 21. Febr. 2019
Barlam TF, Cosgrove SE, Abbo LM et al (2016) Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 62(10):e51–e77
Davey P, Marwick CA, Scott CL et al (2017) Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2:CD003543
Dingle KE, Didelot X, Quan TP et al (2017) Effects of control interventions on Clostridium difficile infection in England: an observational study. Lancet Infect Dis 17(4):411–421
Lawes T, Lopez-Lozano JM, Nebot CA et al (2017) Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis. Lancet Infect Dis 17(2):194–206
Hurst AL, Child J, Pearce K, Palmer C, Todd JK, Parker SK (2016) Handshake Stewardship: A Highly Effective Rounding-based Antimicrobial Optimization Service. Pediatr Infect Dis J 35(10):1104–1110
Bundesärztekammer (2017) Strukturierte curriculare Fortbildung „Antibiotic Stewardship (ABS). https://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/pdf-Ordner/Fortbildung/Antibiotic_Stewardship.pdf . Zugegriffen: 21. Febr. 2019
Robert Koch-Institut (RKI) (2013) Surveillance nosokomialer Infektionen sowie die Erfassung von Krankheitserregern mit speziellen Resistenzen und Multiresistenzen. Bundesgesundheitsbl 56:580–583
Kumar N, Miyajima F, He M et al (2016) Genome-Based Infection Tracking Reveals Dynamics of Clostridium difficile Transmission and Disease Recurrence. Clin Infect Dis 62(6):746–752
Knetsch CW, Lawley TD, Hensgens MP, Corver J, Wilcox MW, Kuijper EJ (2013) Current application and future perspectives of molecular typing methods to study Clostridium difficile infections. Euro Surveill 18(4):20381
Wilcox MH, Shetty N, Fawley WN et al (2012) Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis 55(8):1056–1063
Robert Koch-Institut (RKI) (2016) IfSG-Meldepflicht-Anpassungsverordnung: Zur Umsetzung der neuen Meldepflichten. Epidem Bull 16:135–136
Rights and permissions
About this article
Cite this article
Hygienemaßnahmen bei Clostridioides difficile-Infektion (CDI). Bundesgesundheitsbl 62, 906–923 (2019). https://doi.org/10.1007/s00103-019-02959-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00103-019-02959-1